Tea Tree Oil: Antifungal Potential and Applications
Year: 2026
Type: article
Abstract: As antimicrobial resistance levels soar, accompanied by frequent relapses and negative side effects of available synthetic antifungals, fungal infections pose an ever-increasing global concern for public health. Among numerous broadly acting, broad-spectrum, natural agents, tea tree oil (TTO) extracted from Melaleuca alternifolia has proved promising. Undergoing standardized evaluation to comply with the ISO 4730 criteria, namely a minimum 30% terpinen-4-ol content and 1,8-cineole max 15%, it is a bioactive, monoterpenoid-rich, chemically complicated, well-tolerated natural oil. Lipophilic disruption of the membrane lipid structure is its prevalent antifungal property, leading to altered electrical potential, cytoplasmic leakage, suppression of biofilm genesis, and cell destruction. Clinical studies with topical application have further confirmed the useful application of TTO for superficial skin and mucosal fungal infection sites, namely tinea pedis and subungual mycosis as well as mucosal candidiasis. Although ~10% formulations ameliorate skin conditions for better symptomatology with the advantage of significant anti-inflammatory activities, 25–50% preparations or combinations with existing synthetic drugs are generally recommended for the entire eradication of mycosis. Recent nanotechnological approaches, including solid lipid nanoparticles (SLNs), nanoemulsions, and microcapsules, have been introduced to tackle with the issues of the inherent low aqueous solubility of TTO, skin irritation upon external use, and volatility and oxidation properties. The current article reports botanical sources, chemical standardization guidelines and characteristics, cell damaging mechanism, clinical data, modern developments in nanovehicular delivery systems of TTO and a safety perspective on antifungal treatments.
Language: English
Subfield: Food Science
Domain: Life Sciences
Keywords: tea tree oil, Melaleuca alternifolia, antifungal activity, terpinen-4-ol, 1,8-cineole, monoterpenoids, biofilm inhibition, tinea pedis, mucosal candidiasis, topical antifungal formulation, solid lipid nanoparticles, nanoemulsions, microcapsules, nanoparticle drug delivery, chemical standardization, antimicrobial resistance
Open Access status: green
OpenAlex ID: W7227129184
